Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Red Eye Global Challenge
Anterior Segment Health Economics and Policy News

Red Eye, Global Challenge

Narrative review calls for clearer guidance on noninfectious conjunctival hyperemia

3/18/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Clinical Scorecard: Red Eye, Global Challenge

At a Glance

CategoryDetail
ConditionNoninfectious conjunctival hyperemia
Key MechanismsLifestyle and environmental factors including digital eye strain, contact lens wear, cosmetics, smoking, and pollution.
Target PopulationIndividuals experiencing chronic or recurrent redness, particularly those with dry eye disease and ocular allergy.
Care SettingOphthalmology clinics and general healthcare settings.

Key Highlights

  • Conjunctival hyperemia is a common global ophthalmic presentation.
  • Dry eye disease and ocular allergy are leading causes of redness.
  • Low-dose brimonidine 0.025% shows promise for redness reduction without tachyphylaxis.
  • There is a lack of dedicated management guidelines for noninfectious conjunctival hyperemia.
  • Patients increasingly seek redness relief for cosmetic reasons.

Guideline-Based Recommendations

Diagnosis

  • Clearer diagnostic pathways are needed to differentiate benign redness from sight-threatening emergencies.

Management

  • Consensus recommendations for management of noninfectious conjunctival hyperemia are warranted.

Monitoring & Follow-up

  • Long-term real-world data on treatment efficacy and safety is necessary.

Risks

  • Caution against surgical 'eye-whitening' procedures due to potential serious complications.

Patient & Prescribing Data

Patients experiencing redness due to noninfectious causes, particularly those with DED and ocular allergy.

Many patients self-treat with over-the-counter drops, but management is often suboptimal.

Clinical Best Practices

  • Educate patients on the risks of steroid self-medication.
  • Encourage the use of evidence-based pharmacological options like low-dose brimonidine.
  • Promote better screening tools for accurate diagnosis.

References

  • Ophthalmology and Therapy Review

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: